Literature DB >> 14693516

Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans.

Mohammed A S Alem1, L Julia Douglas.   

Abstract

Prostaglandins are now known to be produced by Candida albicans and may play an important role in fungal colonization. Their synthesis in mammalian cells is decreased by inhibitors of the cyclooxygenase isoenzymes required for prostaglandin formation. In the present study, a catheter disk model system was used to investigate the effects of nonsteroidal anti-inflammatory drugs (all cyclooxygenase inhibitors) on biofilm formation by three strains of C. albicans. Seven of nine drugs tested at a concentration of 1 mM inhibited biofilm formation. Aspirin, etodolac, and diclofenac produced the greatest effects, with aspirin causing up to 95% inhibition. Celecoxib, nimesulide, ibuprofen, and meloxicam also inhibited biofilm formation, but to a lesser extent. Aspirin was active against growing and fully mature (48-h) biofilms; its effect was dose related, and it produced significant inhibition (20 to 80%) at pharmacological concentrations. Simultaneous addition of prostaglandin E(2) abolished the inhibitory effect of 25 or 50 micro M aspirin. At 1 mM, aspirin reduced the viability of biofilm organisms to 1.9% of that of controls. Surviving cells had a wrinkled appearance, as judged by scanning electron microscopy, and consisted of both yeasts and hyphae. Treatment with other cyclooxygenase inhibitors, such as etodolac, resulted in biofilms that consisted almost entirely of yeast cells. In conventional assays for germ tube formation, these drugs produced significant inhibition, whereas aspirin had little effect. Our findings suggest that cyclooxygenase-dependent synthesis of fungal prostaglandin(s) is important for both biofilm development and morphogenesis in C. albicans and may act as a regulator in these physiological processes. Our results also demonstrate that aspirin possesses potent antibiofilm activity in vitro and could be useful in combined therapy with conventional antifungal agents in the management of some biofilm-associated Candida infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693516      PMCID: PMC310207          DOI: 10.1128/AAC.48.1.41-47.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Potentiation of susceptibility to aminoglycosides by salicylate in Escherichia coli.

Authors:  M Aumercier; D M Murray; J L Rosner
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule.

Authors:  Gordon Ramage; Stephen P Saville; Brian L Wickes; José L López-Ribot
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

3.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans.

Authors:  A Kalo-Klein; S S Witkin
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

6.  The use of nonsteroidal antiinflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers.

Authors:  B F Farber; A G Wolff
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

Review 7.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12.

Authors:  J L Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  A localized vaginal allergic response in women with recurrent vaginitis.

Authors:  S S Witkin; J Jeremias; W J Ledger
Journal:  J Allergy Clin Immunol       Date:  1988-02       Impact factor: 10.793

Review 10.  Candida biofilms and their role in infection.

Authors:  L Julia Douglas
Journal:  Trends Microbiol       Date:  2003-01       Impact factor: 17.079

View more
  59 in total

Review 1.  Prevention of catheter-associated urinary tract infection.

Authors:  Barbara W Trautner; Richard A Hull; Rabih O Darouiche
Journal:  Curr Opin Infect Dis       Date:  2005-02       Impact factor: 4.915

Review 2.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

3.  Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism.

Authors:  Andreza Urba de Quadros; Daniel Bini; Priscilla Aparecida Tartari Pereira; Estela Glória Moroni; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2011-06-29       Impact factor: 2.099

4.  Innovative Physical Approaches for Onychomycosis: Peeling, Lasers and Beyond.

Authors:  Sidharth Sonthalia; Mohamad Goldust
Journal:  Skin Appendage Disord       Date:  2019-03-01

Review 5.  Antimicrobial Effects of Antipyretics.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Involvement of the pleiotropic drug resistance response, protein kinase C signaling, and altered zinc homeostasis in resistance of Saccharomyces cerevisiae to diclofenac.

Authors:  Jolanda S van Leeuwen; Nico P E Vermeulen; J Chris Vos
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

7.  From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms.

Authors:  Christopher G Pierce; Anand Srinivasan; Anand K Ramasubramanian; José L López-Ribot
Journal:  Microbiol Spectr       Date:  2015-06

Review 8.  Antifungal adjuvants: Preserving and extending the antifungal arsenal.

Authors:  Arielle Butts; Glen E Palmer; P David Rogers
Journal:  Virulence       Date:  2016-07-26       Impact factor: 5.882

9.  Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.

Authors:  Yun-Gi Kim; Kankanam Gamage Sanath Udayanga; Naoya Totsuka; Jason B Weinberg; Gabriel Núñez; Akira Shibuya
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

10.  Characterization of prostaglandin E2 production by Candida albicans.

Authors:  John R Erb-Downward; Mairi C Noverr
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.